DermaSensor, Inc.

Thank you Ainsley MacLean, M.D., and the Ainsley Advisory Group, for recognizing and highlighting our visionary CEO, Cody Simmons! Like, share and follow us for the latest updates! #HealthTechLeaders #AIinHealthcare #MedTech #Spotlight #SkinCancerAwareness

Concerning trend alert: Melanoma cases are projected to increase by 5.9% in 2025, according to The Skin Cancer Foundation's updated Facts & Statistics (following the American Cancer Society's 2025 report*). Despite abundant prevention information, this deadly form of skin cancer continues to rise across the United States. As Skin Cancer Awareness Month approaches in May, let's prioritize prevention and skin health checks. At DermaSensor, we're committed to transforming skin cancer detection. With a 96% device sensitivity for detecting all skin cancers** our technology supports more confident clinical decisions. Physicians: Talk to your patients about their suspicious lesions. Early assessment of concerning suspicious lesions can be lifesaving. #SkinCancerAwareness #MelanomaDetection #HealthcareInnovation #Dermasensor #EarlyDetectionSavesLives #MedicalDevice #SkinCancer #SkinHealth #MedicalDevice #MedTech #HealthTech #PrimaryCare #Patients *Reference: https://lnkd.in/eTvpWyf ** Clinical evidence upon request

The data speaks for itself. In an FDA pivotal study led by the Mayo Clinic and conducted across 22 centers with over 1,000 patients, the DermaSensor device achieved 96% sensitivity across 224 skin cancers. Even more, a negative result had a 97% chance of being benign for all skin cancers.* In a companion clinical utility study with 108 physicians, the DermaSensor device was found to decrease the number of missed skin cancers by half (from 18% to only 9%), increasing the physicians’ accuracy and confidence in assessing cancerous lesions.* 👏 Special shout-out to Jack Kalavritinos for featuring DermaSensor on WJLA-TV with The Armstrong Williams Show , shining a spotlight on the groundbreaking work of Washington Health Innovation Council (WHIC) partner DermaSensor, Inc. Like, share, and follow us! *Reference: https://lnkd.in/e-pNU886 #SkinCancerAwareness #FDAcleared #MedTech #PrimaryCare #DermaSensor #EarlyDetectionMatters #InnovationInCare #ClinicalConfidence #CancerDetection

Article: Best Healthcare Providers for AI-Optimized Advanced Skin Therapies AI-optimized skin therapies are revolutionizing dermatological care by providing physicians with diagnostic tools that can detect conditions with unprecedented accuracy and speed. These intelligent systems enable doctors to create truly personalized treatment plans based on the comprehensive analysis of skin type, genetic markers, and treatment history. With real-time AI calibration of devices, physicians can now deliver safer procedures with reduced risks and shorter recovery times for their patients. AI extends physician care beyond the clinic through remote monitoring capabilities, creating more efficient workflows while maintaining quality patient support after treatment. Read full article: https://lnkd.in/eaB-xcJs #AIinDermatology #PhysicianTools #SkinCancer #Dermatology #Medical #Melanoma #BasalCellCarcinoma #SquamousCellCarinoma #AIinHealthcare

DermaSensor: Revolutionizing Skin Cancer Assessment for Busy Physicians Our device is designed to support healthcare professionals in delivering immediate, objective results. Using advanced technology, DermaSensor provides an immediate skin cancer assessment in less than 30 seconds, seamlessly integrating into your clinical workflow. Enhance your clinical practice with DermaSensor today! Watch the video below to see DermaSensor in real time. Like, share, and follow us. #Patient #Healthcare #SkinCancer #Testimonials #Melanoma #MedicalDevice #MedTech #HealthTech #Sunscreen #MedTech

DermaSensor Featured in The Washington Post! We’re proud to see one of our valued customers, Dr. Mitchell A Kline MD of NewYork-Presbyterian Hospital Weill Cornell Medicine Center, featured in a recent Washington Post article on the future of AI in skin cancer detection. 🩺 Dr. Kline highlights how handheld tools like DermaSensor can expand access skin cancer risk detection, especially in underserved communities. “The real potential value of the tools is for clinicians whose ability to diagnose is less reliable and who don’t have access to other diagnostic devices,” Dr. Kline shared. We’re excited to be part of the future of skin cancer detection—where AI can enhance the quality of healthcare delivery. Read more: https://lnkd.in/eP6EWBBe #SkinCancerAwareness #AIinHealthcare #EarlyDetection #PrimaryCare #HealthTech #MedicalDevice #MedTech #DermatologyInnovation #Healthcare

Exciting News! Our CEO, Cody Simmons, was recently featured in an insightful article by The Healthcare Technology Report! In the interview, he dives into the journey behind DermaSensor, Inc. and how we’re building tools that fit the hands that need them most— primary care providers (PCPs) who are considered the first line of defense in identifying and managing health problems. It’s all about making healthcare more accessible, efficient, and impactful. 👉 Read full article below Like, share, and follow us for more insights into DermaSensor: the first FDA Cleared handheld skin cancer detection device. #HealthTech #MedTech #SkinCancer #Physician #Healthcare #AIinHealthCare #SkinCancerAwareness #PrimaryCare #MedicalInnovation #FounderStory #EquityInCare

Thank you for visiting DermaSensor at Tech Hub at the American College of Physicians Internal Medicine Meeting 2025 in New Orleans! At DermaSensor, we recognize a significant gap in the effective assessment of skin cancer risk, a critical concern for both patients and for clinicians who are not experts in dermatology. Our mission is to bridge this gap by delivering objective, reliable solutions that empower physicians to non-invasively test for skin cancer risk at the point of care. The significant interest and positive feedback around our device at the Internal Medicine Meeting 2025 was remarkable. It's clear that we are truly helping internal medicine physicians bridge this gap in skin cancer detection. Join the DermaSensor Revolution, like, share, and follow us. To learn more about our technology, pricing, and reimbursement options. Visit: https://lnkd.in/evaMxZHm #InternalMedicine2025 #MedicalInnovation #NewOrleans #Conference #SkinCancer #FamilyPhysician #Lousiana #MeetTheTeam #LiveDemo #Healthcare #MedicalDevice #IM2025 #InternalMedicine

DermaSensor will be at the ACP Internal Medicine Meeting 2025 this week! American College of Physicians Stop by Tech Hub #2113 for a live demo and learn how to implement DermaSensor into your practice. Meet our team: •Ruth Stachura, MBA, National Sales Director •Jacqueline Barberena, Senior Marketing Director •Dr. Kiran Chatha, Associate Director of Clinical and Medical Affairs #MedicalInnovation #NewOrleans #Conference #SkinCancer #FamilyPhysician #Lousiana #MeetTheTeam #LiveDemo #Healthcare #MedicalDevice #IM2025 #InternalMedicine

Exciting Moment at eMerge Americas: DermaSensor Shines in Miami! DermaSensor was selected as one of the top 25 startups in the late-stage startup competition at eMerge Americas in Miami last week! CEO and Co-Founder Cody Simmons delivered an inspiring pitch that highlighted: •Critical skin cancer statistics •Personal motivation behind DermaSensor's mission •Innovative approach to skin cancer detection Cody's journey was deeply personal, inspired by his mother's skin cancer diagnosis, and developed in collaboration with Dr. Maurice R. Ferre M.D. Click on the video below for a snippet! Like, share, and follow us for the latest updates. #Miami #SkinCancer #MedicalDevice #MedTech #HealthTech #Presentation #Healthcare #Physician #SkinCancerAwareness